top of page

BPC-157: What the Research Says About This Protective Peptide

Updated: Jun 29

Research scientist studying BPC-157 peptide compound mechanisms in laboratory

BPC-157 — short for Body Protection Compound 157 — has become one of the most discussed peptides in regenerative research over the past two decades. Despite being derived from a protein found in human gastric juice, its range of studied effects extends well beyond the gut.

New to peptide research? Start with our guide on what peptides are and how they work before diving in.

What Is BPC-157?

BPC-157 is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a sequence found in human gastric juice. The full sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is not naturally occurring in this exact form; it is a stable fragment isolated and studied for its biological activity.

What makes BPC-157 particularly interesting is its remarkable stability. Unlike many peptides that degrade quickly, BPC-157 is resistant to enzymatic breakdown — which may contribute to its sustained activity in preclinical models.

The Research: Key Areas of Study

Tissue and Tendon Repair

Multiple rodent studies show accelerated tendon-to-bone healing, with researchers noting upregulation of growth hormone receptors at injury sites. Studies on Achilles tendons, rotator cuff injuries, and ligament damage all show improved healing rates vs. controls.

Gastroprotection and Gut Health

Given its origin in gastric juice, BPC-157's GI effects are among the most studied. Research shows protective effects against gastric ulcers, IBD-like lesions, and NSAID-induced gut damage in animal models.

Neurological and Systemic Effects

Animal studies report effects on dopamine and serotonin systems, with data suggesting neurotransmitter modulation relevant to mood, motivation, and neuroprotection after TBI.

How BPC-157 Is Thought to Work

  • Nitric oxide (NO) modulation — influencing vascular tone, blood flow, and tissue oxygenation.

  • Growth hormone receptor upregulation — amplifying local repair signals at injury sites.

  • VEGF pathway activation — driving angiogenesis and improving vascularization of healing tissue.

  • Anti-inflammatory signaling — reducing pro-inflammatory cytokine activity.

  • Dopamine and serotonin system interaction — studied in neurological and behavioral research.

Where the Research Stands

The overwhelming majority of BPC-157 evidence comes from animal studies. There are no large-scale, randomized human clinical trials. It is not FDA-approved — it is a research compound only.

BPC-157 is reconstituted with bacteriostatic water before use. For a comparison with TB-500, see our BPC-157 vs. TB-500 guide.

Frequently Asked Questions: BPC-157

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a sequence found in human gastric juice. It is not naturally occurring in this exact form; it is a stable fragment studied for its wide-ranging biological activity in preclinical research, particularly in tissue healing, gut protection, and neurological effects.

What does the research say about BPC-157?

The majority of BPC-157 research comes from rodent and in vitro studies. These consistently show accelerated tendon-to-bone healing, protection against NSAID-induced gut damage, mucosal healing in IBD-like models, and modulation of dopamine and serotonin systems. Several independent research groups have replicated these findings. Large-scale human clinical trials have not been conducted.

Is BPC-157 FDA approved?

No. BPC-157 is not FDA approved and is not legal for human use. It is sold strictly as a research compound for laboratory and preclinical research purposes only.

How does BPC-157 work?

BPC-157 is thought to work through several mechanisms: modulation of the nitric oxide (NO) system; upregulation of growth hormone receptors at injury sites; activation of VEGF pathways driving angiogenesis; anti-inflammatory cytokine reduction; and interaction with dopamine and serotonin systems.

How is BPC-157 reconstituted for research?

BPC-157 is supplied as a lyophilized powder and reconstituted with bacteriostatic water (BAC water) before use. Add BAC water slowly to the vial wall, swirl gently (do not shake), and store at 2–8°C.

What is the difference between BPC-157 and TB-500?

BPC-157 is a 15-amino-acid gastric peptide fragment studied for tendon healing, gut protection, and neurological effects via NO/VEGF pathways. TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide that primarily works by regulating actin polymerization, promoting cell migration and wound healing. They are considered complementary.

How should BPC-157 be stored?

Lyophilized BPC-157 should be stored at -20°C, away from light and moisture, where it can remain stable for 1–2 years. Once reconstituted in bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.

Source Research-Grade BPC-157 from Golden State BIO

Golden State BIO BPC-157 research peptide product

Golden State BIO offers research-grade BPC-157 synthesized to ≥98% purity with third-party HPLC verification. Every batch ships lyophilized for maximum stability.

The Bottom Line

BPC-157's stability, multi-system activity, and consistent preclinical results make it one of the more compelling research peptides available.

 
 
 

Comments


bottom of page

test